Logo Image
Feature|Videos|April 16, 2026

Scaling for Growth: Inside Tjoapack’s US Expansion Strategy

Key Takeaways

  • Understand the strategic drivers behind Tjoapack’s US expansion and how increasing packaging capacity supports growing client demand in the pharmaceutical supply chain.
  • Explore how expanded capabilities influence client partnerships and competitive positioning in the contract packaging (CPO) landscape.
SHOW MORE

Peter Belden, Tjoapack, discusses how the rise of specialized medicines for smaller patient populations is necessitating more flexible, redundant packaging capacity to manage complex global distribution requirements.

Sponsored by Tjoapack

Peter Belden, Chief Commercial Officer at Tjoapack, explains that the company’s US expansion is primarily driven by the rapid acceleration of specialized medicines and treatments for smaller, often underserved patient populations.

This shift in drug development has created a significant need for flexible, nimble outsource packaging services that can adapt to unique requirements more effectively than larger, traditional contract packagers. By targeting mid-market and emerging biopharma manufacturers, Tjoapack is positioning itself to support the entire lifecycle of these complex molecules.

The current expansion builds upon previous investments in Europe to create a redundant, two-continent platform designed for long-term growth over the next 5 to 10 years. This infrastructure allows Tjoapack to offer a wide range of capabilities, including oral solid doses, injectables, and cold chain management, as well as specialized compliance packaging. The addition of expanded automation and physical capacity ensures that the company can handle both standard scalable solutions and highly customized packaging needs.

Ultimately, these strategic investments transform Tjoapack into a global supply chain hub, providing the planning tools and resources necessary for manufacturers to reach patients in 40 to 50 countries. By offering global logistics support and coordination, Tjoapack aims to be the preferred partner for biopharma sponsors navigating the complexities of commercializing medicines in both major Western markets and emerging global territories.

Related Content